| |
INTRODUCING HOLOFIBER, WORLD’S FIRST BODY-RESPONSIVE
TEXTILE
Independent Studies Prove Holofiber’s
Ability To Improve Circulation, Speed Recovery And Boost Energy Levels
Major Manufacturers Incorporating Holofiber into Product Lines
NEW YORK (November 17, 2003) — Hologenix, a
joint venture between Holofiber Enterprises Inc. and Wellman, Inc.,
today introduced Holofiber, the world's first body-responsive textile
fiber. Holofiber has been scientifically proven to significantly increase
oxygenated blood flow, which can increase circulation and build strength.
For diabetics, this improvement in skin oxygenation can accelerate
wound healing and help eliminate pain due to decreased blood flow.
For people not affected by diabetes, this skin oxygenation helps speed
recovery after exercise, boost energy levels and improve overall circulation.
Diabetics face two major issues: neuropathy, or the loss of sensation,
and atherosclerosis, or hardening of the arteries, which reduces the
circulation of blood in the body. Atherosclerosis can lead to a number
of conditions, including aching feet, leg pain and problems with wound
healing. Symptoms include cold feet, pain in the legs when walking
and pain in the feet when reclining. When worn on or near the skin,
Holofiber responds to available light and the energy produced naturally
by the body, converting light and the body’s own energy into
the necessary wavelengths that make this usually unavailable energy
accessible to the body – thereby improving the body’s
circulation and oxygen levels.
In addition to helping diabetics, this breakthrough textile has been
shown to improve physical performance and recovery time among those
without circulation problems. Holofiber is already being lauded by
some of the world’s top athletes, including top-ranked female
triathlete and Olympic silver medalist Michellie Jones, who has been
testing Holofiber for nearly two years.
“As a professional athlete, you want everything you can possibly
find to help get the best performance possible,” noted Jones.
“That’s one of the things I like about Holofiber –
the fact that it helps with recovery and circulation. What better
way – there’s no extra effort, and it really helps and
benefits you."
Robert Klein, co-founder and chairman of Holofiber Enterprises, noted,
“If Holofiber can increase the recovery time of one of the world’s
leading athletes, imagine its potential for average consumers, both
those with blood flow problems as well as healthy people.”
Clinical Studies Evaluate Holofiber
A double blind clinical study conducted by Dr. Lawrence Lavery of
Texas A&M University, one of the world's leading experts in diabetic
foot complications, proved the effectiveness of Holofiber products
in increasing oxygen levels in diabetic subjects. According to Dr.
Lavery, there was a “…statistically significant change
in transcutaneous oxygen – or the oxygen delivery to the skin
– in hands and feet, on subjects wearing Holofiber gloves and
socks compared to those wearing comparable non-Holofiber gloves and
socks.”
Following these findings, another double-blind study, conducted by
Graham McClue PhD., with Dr. Lavery, was commissioned to determine
if this fiber could produce the same results in non-compromised, or
healthy, subjects. In both studies, Holofiber increased oxygen levels
in both diabetic and non-challenged subjects by as much as 25%.
In addition, two other studies on Holofiber are currently underway:
- Personnel stationed at the National Science Foundation’s
(NSF) Summit Camp in Greenland, where the average daily temperature
is 30 degrees below zero Fahrenheit, are currently testing Holofiber’s
abilities to better protect the body in adverse weather conditions.
- Dr. Richard Brown of the Eugene Health & Performance Foundation,
who has coached women athletes in endurance events in each of the
last five Olympic Games, is evaluating the effects of Holofiber on
sports performance and recovery. Recording performance differences
between subjects wearing Holofiber products versus those who are not,
the study involves multiple runs on a treadmill while monitoring total
heart rate at a specific rate of increase in exercise intensity.
Manufacturers Taking Advantage of Holofiber
Among the manufacturers already offering Holofiber products or planning
to introduce them are Wickers tees, shorts, sock and glove liners
at www.wickers.com; SuperFeet custom insoles available through www.superfeet.com
and at REI retailers nationwide; Achieve O2 diabetic and medical socks
at www.achieve-O2.com; Callaway Golf shoes at www.callawaygolffootwear.com;
and others, available on the Holofiber website at www.holofiber.com.
More manufacturers will be announced in the coming weeks and months.
About Holofiber
Holofiber is a proprietary product with patent pending. It is a responsive
material for textiles and other uses, and is not an additive or coating
applied by spraying or dipping. Its properties do not wash or leach
out of the fabric. All of the Holofiber materials are incorporated
into the fiber (becoming part of the fiber) and are non-toxic and
biologically benign. Additional information is available upon request
or at www.holofiber.com.
About Hologenix
Hologenix, LLC is a joint venture between Wellman, Inc. (NYSE: WLM)
and Holofiber Enterprises, Inc., formed to manufacture and market
Holofiber. Wellman, a leading manufacturer of synthetic fibers and
Holofiber Enterprises, a company engaged in leading edge research
and development, have been actively developing this product and supporting
scientific testing for nearly two years.
About Wellman
Wellman, Inc. manufactures and markets high-quality polyester products,
including Fortrel® brand polyester fibers, and PermaClear®
and EcoClear® brand PET (polyethylene terephthalate) packaging
resins. The world’s largest PET plastic recycler, Wellman utilizes
a significant amount of recycled raw materials in its manufacturing
operations.
For more information, contact:
Product:
Jim Ciccone
Hologenix, LLC.
704.357.2170
jim.ciccone@hologenixllc.com
Media:
Jay Roberts or Jessica Murphy
SAVVY Partners, Inc.
212.813.3845 / 212.813.3838
jay@savvypartnersinc.com
jessica@savvypartnersinc.com
Return to Press Releases main page >
|
|
|
